What does this research mean for the field?

Sarcopenia is a modifiable therapeutic target in hepatocellular carcinoma, and treating it with nutritional therapy and exercise alongside standard HCC treatments can improve patient outcomes. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

August 11, 2026Current Hepatology ReportsOpen Access

Sarcopenia and Frailty in Hepatocellular Carcinoma: From Prognostic Marker to Therapeutic Target: A Narrative Review

View Full Paper

Ask AI

Bookmark

Authors

BBBrittany Bromfield ARAstrid Ruiz‐Margáin LKLaura Kulik

Discussion

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Bromfield et al. (2026) studied this question.

synapsesocial.com/papers/6a7cb6ff4ec837fd6928a954 https://doi.org/10.1007/s11901-026-00745-7

View Full Paper

Ask AI

Bookmark

August 11, 2026Current Hepatology ReportsOpen Access

Sarcopenia and Frailty in Hepatocellular Carcinoma: From Prognostic Marker to Therapeutic Target: A Narrative Review

View Full Paper

Ask AI

Bookmark

Authors

BBBrittany Bromfield ARAstrid Ruiz‐Margáin LKLaura Kulik

Discussion

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Bromfield et al. (2026) studied this question.

synapsesocial.com/papers/6a7cb6ff4ec837fd6928a954 https://doi.org/10.1007/s11901-026-00745-7

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark